Search
for
Sort by
Research 30 of 1000+
- LB1681 Risk of merkel cell carcinoma progression after treatment discontinuation in patients with an objective response to anti-PD-(L)1 immunotherapy
- Alopecia and hair repigmentation associated with anti-programmed death-ligand 1 (PD-L1) immunotherapy
- Anti-programmed cell death protein 1-induced lichenoid changes of the nail unit: Histopathologic description
- 183 PD-1 regulatory network is upregulated in contact immunotherapy during alopecia areata treatment
- N6-methyladenosine RNA Methylation Correlates with Immune Microenvironment and Immunotherapy Response of Melanoma
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- Global trends in tertiary lymphoid structures: a bibliometric analysis from 2014 to 2023
- Age-associated inflammation connects RAS-induced senescence to stem cell dysfunction and epidermal malignancy
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Sintilimab-induced Alopecia Universalis in a Patient With the Anti-tumor Effect of Complete Remission After Hepatectomy
- Tregs: Where We Are and What Comes Next?
- Investigation the role of SIRT3, SIRT7, NFATC1, and PDL-1 genes in androgenetic alopecia
- Role of the SOX family in cancer immune evasion: Emerging player and promising therapeutic opportunities
- Persistently curly hair phenotype with the use of nivolumab for squamous cell lung cancer
- Protective Effect of Iris germanica L. Rhizome-Derived Exosome against Oxidative-Stress-Induced Cellular Senescence in Human Epidermal Keratinocytes
- UTMD Enhances Targeting of Diclofenac and Doxil® to Boost Tumor Immunotherapy
- Management of Toxicities of Targeted Therapies
- Immunosenescence and inflammaging in Parkinson’s disease: mechanisms and therapeutic prospects
- Targeted protein degradation of Wnt/β-catenin signaling pathway: an effective strategy for cancer therapy
- Regulatory T cell dysfunction and immunotherapeutic breakthroughs in type 1 diabetes
- Anais do II Congresso Nacional Acadêmico de Dermatologia
- Topische Immuntherapie mit Diphenylcyclopropenon bei verschiedenen Typen der Alpecia areata: Assoziation zu klinischen Parametern und einem funktionellen Genpolymorphismus des Interleukin-6-Promotors
- Alopecia Areata
- Immunomodulatory Effects of Platelet-Rich Plasma (PRP) on Neuroinflammation: Insights from B92 Glial Cells Stimulated with Heat-Killed Escherichia coli
- An In Situ Chemotherapy Drug Combined with Immune Checkpoint Inhibitor for Chemoimmunotherapy
- Comparative Analysis of Plant Exosomes and Human-Derived Exosomes: Structural Differences and Emerging Applications
- Toll-like receptor-targeted anti-tumor therapies: Advances and challenges
- Efficacy and safety of a novel anti‐HER2 therapeutic antibody RC48 in patients with HER2‐overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single‐arm phase II study
- What's new in the pathogeneses and triggering factors of bullous pemphigoid
- Topical delivery of nanoemulsions for skin cancer treatment